Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Google Responds to ChatGPT With Its Own Bard Offering
Google Responds to ChatGPT With Its Own 'Bard'
Goldman Sachs: Odds of Recession Down 25 Percent
Goldman Sachs: Odds of Recession Down 25 Percent
Shift in Consumer Spending Habits
Cheddar News breaks down the findings of Shipstation's Ecommerce Delivery Benchmark Report, including the latest shifts in consumer spending habits and how businesses can strategize for success.
Wall Street Rallies After Swerving on Fed Chair's comments
Stocks closed higher on Wall Street after the head of the Federal Reserve signaled last week’s stunningly strong jobs report isn’t likely to change where interest rates are heading on its own, as some investors had feared.
Market Minute: Rivian Mulls E-Bike, AMC Launches Tiered Seats & AI Rivalry
Here is a rundown of Cheddar News' top trending market stories of the day.
Boeing Cutting 2,000 HR, Finance Roles as It Ramps Up Production
Boeing is cutting 2,000 jobs in its human resources and finance departments in 2023 amid a broader push to increase hiring.
Google Reveals Chatbot in Response to Microsoft-Backed OpenAI
Chatbots are all the rage since Microsoft-backed OpenAI launched ChatGPT late last year. Now other tech giants are rolling out their own contributions to the artificial intelligence space, with Google owner Alphabet on Tuesday announcing the launch of a chatbot service called Bard.
Cheddar Morning News Briefings of February 7th
Cheddar Morning News Briefings
Today Explained: How Rising Costs Are Depleting Trillions in Saved Funds From Pandemic Savings
As fears of recession loom, the consumer price index up 6.5 percent and inflation at historic highs, funds that Americans saved during the COVID-19 pandemic are nearing depletion.
